glp-1 agonists medications receptor GLP-1 Agonists: A Comprehensive Overview

Description

2024 doi: 10.1177/87551225241289959

Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that was recently approved by the FDA for the treatment of type 2 diabetes

Notably, semaglutide and exenatide showed higher NAE proportions (16.97% and 14.44%, respectively) compared to tirzepatide (6.06%)

How Orforglipron Works Orforglipron works by: Slowing how quickly food leaves the stomach Helping you feel full sooner Reducing appetite signals Supporting healthier blood sugar levels Because of these effects, researchers consider it a meaningful step forward in the search for easier, needle-free treatments for obesity